Although we did not observe changes in cholesterol levels in the SmarcAL1 KO mice (see Discussion), the downregulation of LDLR expression aligns with the hypercholesterolemia observed in SIOD patients. Here, SMARCAL1 is linked to familial hypercholesterolemia.